C C Huijbregts

608 total citations
12 papers, 506 citations indexed

About

C C Huijbregts is a scholar working on Genetics, Hematology and Oncology. According to data from OpenAlex, C C Huijbregts has authored 12 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 9 papers in Hematology and 3 papers in Oncology. Recurrent topics in C C Huijbregts's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (11 papers), Hemophilia Treatment and Research (5 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). C C Huijbregts is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (11 papers), Hemophilia Treatment and Research (5 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). C C Huijbregts collaborates with scholars based in Netherlands. C C Huijbregts's co-authors include Jan H. Nuijens, C. Erik Hack, C.E. Hack, L. G. Thijs, Jannie J. Abbink, J. Abbink, L. G. Thijs, A J Eerenberg-Belmer, W. O. Schreuder and R. J. F. Felt‐Bersma and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

In The Last Decade

C C Huijbregts

12 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C C Huijbregts Netherlands 10 321 313 132 98 58 12 506
Eugénia Cruz Portugal 14 154 0.5× 223 0.7× 99 0.8× 129 1.3× 24 0.4× 30 460
Laura Tabellini United States 10 203 0.6× 308 1.0× 264 2.0× 29 0.3× 52 0.9× 13 613
LA Harker United States 10 150 0.5× 553 1.8× 50 0.4× 32 0.3× 54 0.9× 13 629
J. M. Lavergne France 18 151 0.5× 759 2.4× 134 1.0× 39 0.4× 20 0.3× 47 955
A. von Rohr Switzerland 13 275 0.9× 154 0.5× 122 0.9× 14 0.1× 28 0.5× 25 530
K Likert United States 8 243 0.8× 665 2.1× 45 0.3× 25 0.3× 128 2.2× 9 788
Idanna Innocenti Italy 14 336 1.0× 152 0.5× 181 1.4× 11 0.1× 53 0.9× 75 638
S Bettoni Italy 10 96 0.3× 125 0.4× 240 1.8× 11 0.1× 35 0.6× 15 512
EJ Bowie United States 13 164 0.5× 699 2.2× 68 0.5× 18 0.2× 23 0.4× 22 816
R Ramberg United States 8 149 0.5× 363 1.2× 204 1.5× 5 0.1× 28 0.5× 9 640

Countries citing papers authored by C C Huijbregts

Since Specialization
Citations

This map shows the geographic impact of C C Huijbregts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C C Huijbregts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C C Huijbregts more than expected).

Fields of papers citing papers by C C Huijbregts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C C Huijbregts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C C Huijbregts. The network helps show where C C Huijbregts may publish in the future.

Co-authorship network of co-authors of C C Huijbregts

This figure shows the co-authorship network connecting the top 25 collaborators of C C Huijbregts. A scholar is included among the top collaborators of C C Huijbregts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C C Huijbregts. C C Huijbregts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Eldering, Eric, C C Huijbregts, Jan H. Nuijens, AJ Verhoeven, & C. Erik Hack. (1993). Recombinant C1 inhibitor P5/P3 variants display resistance to catalytic inactivation by stimulated neutrophils.. Journal of Clinical Investigation. 91(3). 1035–1043. 11 indexed citations
2.
Eldering, Eric, C C Huijbregts, Jan H. Nuijens, & C.E. Hack. (1993). The balance between inhibition and substrate-type reactions of recombinant C1 inhibitor P5/P3 variants.. PubMed. 125–30. 1 indexed citations
3.
Eldering, Eric, C C Huijbregts, Yvonne T.P. Lubbers, Colin Longstaff, & C.E. Hack. (1992). Characterization of recombinant C1 inhibitor P1 variants.. Journal of Biological Chemistry. 267(10). 7013–7020. 46 indexed citations
4.
Nuijens, Jan H., et al.. (1992). A novel sensitive assay for functional factor XII based on the generation of kallikrein-C1-inhibitor complexes in factor XII-deficient plasma by glass-bound factor XII.. PubMed. 67(6). 644–8. 18 indexed citations
5.
6.
Abbink, Jannie J., Jan H. Nuijens, A. J. M. Eerenberg, et al.. (1991). Quantification of Functional and Inactivated α2-Macroglobulin in Sepsis. Thrombosis and Haemostasis. 65(1). 32–39. 33 indexed citations
7.
Nuijens, Jan H., C C Huijbregts, A J Eerenberg-Belmer, et al.. (1989). Activation of the Contact System of Coagulation by a Monoclonal Antibody Directed Against a Neodeterminant in the Heavy Chain Region of Human Coagulation Factor XII (Hageman Factor). Journal of Biological Chemistry. 264(22). 12941–12949. 27 indexed citations
8.
Nuijens, Jan H., A J Eerenberg-Belmer, C C Huijbregts, et al.. (1989). Proteolytic inactivation of plasma C1- inhibitor in sepsis.. Journal of Clinical Investigation. 84(2). 443–450. 113 indexed citations
9.
Jh, Nuijens, et al.. (1988). Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(- )-inhibitor complexes in sepsis. Blood. 72(6). 1841–1848. 2 indexed citations
10.
Huijbregts, C C, et al.. (1988). Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(- )-inhibitor complexes in sepsis. Blood. 72(6). 1841–1848. 153 indexed citations
11.
Nuijens, Jan H., et al.. (1987). Inactivation of C-1 inhibitor by proteases: demonstration by a monoclonal antibody of a neodeterminant on inactivated, non-complexed C-1 inhibitor.. PubMed. 61(3). 387–9. 39 indexed citations
12.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eugénia Cruz Breakdown of academic impact, for papers by Laura Tabellini Breakdown of academic impact, for papers by LA Harker Breakdown of academic impact, for papers by J. M. Lavergne Breakdown of academic impact, for papers by A. von Rohr Breakdown of academic impact, for papers by K Likert Breakdown of academic impact, for papers by Idanna Innocenti Breakdown of academic impact, for papers by S Bettoni Breakdown of academic impact, for papers by EJ Bowie Breakdown of academic impact, for papers by R Ramberg
Rankless by CCL
2026